| 4C0C: reference: 4-Aminopyridyl-Based CYP51 Inhibitors as Anti-Trypanosoma cruzi Drug Leads with Improved Pharmacokinetic Profile and in Vivo Potency., Calvet CM, Vieira DF, Choi JY, Kellar D, Cameron MD, Siqueira-Neto JL, Gut J, Johnston JB, Lin L, Khan S, McKerrow JH, Roush WR, Podust LM, J Med Chem. 2014 Aug 19. PMID: 25101801 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).